Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;51(12):2408-2417.
doi: 10.1007/s00247-021-05119-3. Epub 2021 Jul 9.

Contrast-enhanced ultrasound in pediatric echocardiography

Shelby Kutty  1 , David M Biko  2 , Alan B Goldberg  3 , Michael D Quartermain  4 , Steven B Feinstein  3
Affiliations
Review

Contrast-enhanced ultrasound in pediatric echocardiography

Shelby Kutty et al. Pediatr Radiol. 2021 Nov.

Abstract

The safety and benefits of cardiac contrast-enhanced ultrasound (CEUS) have been demonstrated in children and adolescents for a variety of clinical indications, including congenital heart disease. Cardiac CEUS is performed with US and the intravenous administration of ultrasound contrast agents (UCAs). It improves transthoracic echocardiography, which can be challenging in children and adults with acoustic window limitations (e.g., from obesity) and alterations in chest wall and cardiac geometry (e.g., from prior surgical procedures). Cardiac CEUS is also used to evaluate ischemia in the follow-up of congenital and acquired heart disease. In 2019, the United States Food and Drug Administration (FDA) approved a UCA for pediatric echocardiography. This article focuses on the clinical applications of UCAs in pediatric and adult echocardiography, outlining its diagnostic value, safety and potential for future applications.

Keywords: Cardiac; Children; Congenital heart disease; Contrast-enhanced ultrasound; Echocardiography; Heart; Ultrasound; Ultrasound contrast agents.

PubMed Disclaimer

References

    1. Abdelmoneim SS, Bernier M, Scott CG et al (2010) Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study. Circ Cardiovasc Imaging 3:240–248 - DOI
    1. Khawaja OA, Shaikh KA, Al-Mallah MH (2010) Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents. Am J Cardiol 106:742–747 - DOI
    1. Main ML, Goldman JH, Grayburn PA (2007) Thinking outside the "box" — the ultrasound contrast controversy. J Am Coll Cardiol 50:2434–2437 - DOI
    1. Calliada F, Campani R, Bottinelli O et al (1998) Ultrasound contrast agents: basic principles. Eur J Radiol 27:S157–S160 - DOI
    1. Gramiak R, Shah PM (1968) Echocardiography of the aortic root. Investig Radiol 3:356–366 - DOI

LinkOut - more resources